ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Life-supporting Multi-gene Cardiac Xenografts From Swine Demonstrate Survival >8 Months and Preclinical Efficacy for Human Clinical Trials

    C. Goerlich1, B. Griffith1, A. Singh1, T. Zhang1, I. Tatarov1, B. Lewis1, F. Sentz1, A. Hershfeld1, P. Odonkor1, B. Williams1, E. Strauss1, A. Tabatabai2, A. Bhutta3, D. Ayares4, D. Kaczorowski1, M. Mohiuddin1

    1Surgery, University of Maryland School of Medicine, Baltimore, MD, 2Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, 3Pediatrics, Pediatric Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, 4Revivicor, Inc., Blacksburg, VA

    *Purpose: Cardiac xenotransplantation has been proposed to bridge the gap in organ shortage for those in end-stage heart failure without the opportunity to receive a…
  • 2021 American Transplant Congress

    Short-term Therapy with Anti-icam-1 Monoclonal Antibody Induced Long-term Liver Allograft Survival in Non-human Primates

    S. Hong1, D. Han2, S. Lee2, J. Kim3, E. Hwang3, H. Kim4, J. Lee5, K. Hong1, E. Han1, J. Cho1, J. Lee1, Y. Choi1, K. Lee1, N. Yi1, J. Yang1, K. Suh1

    1Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of, 2Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Korea, Republic of, 3Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea, Republic of, 4Pathology, Seoul National University College of Medicine, Seoul, Korea, Republic of, 5Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: Tolerance induction remains challenging following liver transplantation and the long-term use of immunosuppressants, especially calcineurin inhibitors, leads to serious complications. We aimed to test…
  • 2021 American Transplant Congress

    Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus Metabolism in African American Kidney Transplant Recipients

    C. R. Dorr1, B. Guo2, B. Wu2, J. Abrahante2, D. Schladt3, R. Remmel2, W. Guan2, A. Muthusamy3, G. Onyeaghala3, N. Pankratz2, A. Matas2, R. Mannon4, W. Oetting2, P. Jacobson2, A. K. Israni3

    1Hennepin Healthcare Research Institute, Minneapolis, MN, 2University of Minnesota, Minneapolis, MN, 3Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, 4University of Nebraska Medical Center, Omaha, NE

    *Purpose: Tacrolimus (TAC) pharmacogenomics studies identified common genetic variants that alter TAC troughs suggesting strategic dosing for specific populations. Common variants and clinical factors explain…
  • 2021 American Transplant Congress

    A Machine Learning-Based Predictive Model for Outcome of Covid-19 in Kidney Transplant Recipients

    I. Revuelta1, F. Santos-Arteaga2, D. Di Caprio3, E. Montagud-Marrahi1, F. Cofan1, J. Torregrosa1, M. Bodro4, A. Moreno4, P. Ventura-Aguiar1, D. Cucchiari1, N. Esforzado1, G. Piñeiro1, J. Ugalde-Altamirano1, J. Campistol1, A. Alcaraz5, B. Bayès1, E. Poch1, F. Oppenheimer1, F. Diekmann1

    1Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, 2Faculty of Economics and Management, Free University of Bolzano, Bolzano, Italy, 3Department of Economics and Management, University of Trento, Trento, Italy, 4Department of Infectious Diseases, Hospital Clinic, Barcelona, Spain, 5Department of Urology, Hospital Clinic, Barcelona, Spain

    *Purpose: Health systems need tools to deal with COVID-19, especially for high-risk population,such as transplant recipients. Predictive models are necessary to improve management of patients…
  • 2021 American Transplant Congress

    Challenges and Stressors of COVID-19 Kidney and Transplant Patients: A Mixed Methods Study

    Y. A. Iraheta1, A. L. Murillo2, E. H. Wood1, S. M. Advani3, R. Pines4, A. D. Waterman1

    1UCLA David Geffen School of Medicine, Los Angeles, CA, 2Terasaki Institute, Los Angeles, CA, 3National Human Genome Research Institute (NIH), Bethesda, MD, 4Santa Barbara Cottage Hospital, Santa Barbara, CA

    *Purpose: To assess the unique needs of at-risk kidney and transplant patients and their caregivers during COVID-19, we established a telephone Listening Center enabling them…
  • 2021 American Transplant Congress

    Successful Long-Term TMA- and Rejection-Free Survival of a Kidney Xenograft With Triple Xenoantigen Knockout Plus Insertion of Multiple Human Transgenes

    T. Hirose1, D. Ma1, G. Lassiter1, H. Sasaki1, I. Rosales2, T. Coe1, C. Rickert1, R. Matheson1, R. Colvin2, W. Qin3, Y. Kan3, J. Layer3, K. Stiede3, K. Hall3, M. Youd3, W. Westlin3, M. Curtis3, J. F. Markmann1, T. Kawai1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Pathology, Massachusetts General Hospital, Boston, MA, 3eGenesis Inc, Cambridge, MA

    *Purpose: Pigs with deletion of 3 carbohydrate xenoantigens (triple knock-out, TKO) are expected to be optimal donors for human xenotransplantation. However, anti-porcine natural antibodies of…
  • 2021 American Transplant Congress

    Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective

    M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones

    University of Alabama at Birmingham Hospital, Birmingham, AL

    *Purpose: Due to direct acting antivirals (DAAs), hepatitis C virus (HCV) positive patients are now resources for organ transplantation in HCV negative recipients. Our institution…
  • 2021 American Transplant Congress

    Does the NSQIP-Transplant Experience Demonstrate That Obese Kidney Transplant Recipients are Still at Increased Risk for Surgical Site Infections?

    H. C. Yaffe1, A. K. Belli1, J. R. Parekh2, D. L. Sudan3, N. Elias4, K. D. Conzen5, D. P. Foley6, R. Hirose7, S. M. Greenstein1

    1Surgery, Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, 2Surgery, University of California San Diego, San Diego, CA, 3Surgery, Division of Abdominal Transplant Surgery, Duke University Medical Center, Durham, NC, 4Surgery, Transplant Surgery Division, Massachusetts General Hospital, Boston, MA, 5Surgery, Division of Transplant Surgery, University of Colorado Hospital, Aurora, CO, 6Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, 7Surgery, University of California San Francisco, San Francisco, CA

    *Purpose: The National Surgical Quality Improvement Program for Transplant (NSQIP-T) was designed to track surgical outcomes in adult liver and kidney transplants (KTX). The Pilot…
  • 2021 American Transplant Congress

    Predicted Heart Mass Difference as a Risk Factor for Severe Primary Graft Dysfunction in the Contemporary Era of Heart Transplantation: A Report from the International Consortium on Primary Graft Dysfunction

    F. Foroutan1, L. K. Truby2, Y. Moayedi1, J. Han3, J. Guzman4, M. Farrero4, E. Baughan5, M. Farr5, H. Zafar6, J. Felius6, J. van Zyl7, D. Law8, S. Chih8, P. Angleitner9, M. Sabatino10, A. DeVore2, R. J. Miller11, L. Potena10, A. Zuckermann9, K. K. Khush3, S. A. Hall6, H. J. Ross1

    1Ted Rogers Centre for Heart Research, Toronto, ON, Canada, 2Duke University School of Medicine, Durham, NC, 3Stanford University, Stanford, CA, 4Clinic Barcelona Hospital Universitari, Barcelona, Spain, 5Columbia University Medical Center, New York, NY, 6Baylor University Medical Center, Dallas, TX, 7Dallas University Medical Center, Dallas, TX, 8University of Ottawa Heart Institute, Ottawa, ON, Canada, 9Medical University of Vienna, Vienna, Austria, 10Bologna University Hospital, Bologna, Italy, 11University of Calgary, Calgary, AB, Canada

    *Purpose: Primary Graft Dysfunction (PGD) increases early mortality after heart transplant (HT). Predicted heart mass (PHM) difference may be a risk factor for PGD. Lack…
  • 2021 American Transplant Congress

    The Intersection of Cost, Quality, and Volume in Liver Transplant

    D. Axelrod1, R. Balakrishnan1, A. Harris2, S. Hohmann2, J. Snyder3, B. Kasiske3, M. Schnitzler4, K. Lentine4

    1Univ of Iowa, Iowa City, IA, 2Vizient Inc., Irving, TX, 3SRTR, Minneapolis, MN, 4Saint Louis Univ, Saint Louis, MO

    *Purpose: As a consequence of changing allocation practices and the ongoing shortage of high-quality organs, the cost of liver transplant (LT) continues to increase throughout…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences